Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Adler

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Rheumatology (Oxford, England)|December 16, 2011
Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination studySabine Adler, Anne Krivine, Janine Weix, et al.
The Journal of Allergy and Clinical Immunology|November 17, 2012
Induction of severe systemic lupus erythematosus by TNF blockade and response to anti-IL-6 strategySabine Adler, Mirjam Kolev, Pierre-Alain Varisco, et al.
Arthritis Research & Therapy|March 14, 2024
Concomitant Sjögren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohortLisa Christ, Seraphina Kissling, Axel Finckh, et al.
Rheumatology (Oxford, England)|March 13, 2018
Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritisStephan Reichenbach, Sabine Adler, Harald Bonel, et al.
Lancet (London, England)|March 9, 2016
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialPeter M Villiger, Sabine Adler, Stefan Kuchen, et al.
PLOS Digital Health|June 27, 2024
Explainable deep learning for disease activity prediction in chronic inflammatory joint diseasesCécile Trottet, Ahmed Allam, Aron N Horvath, et al.
Microlife|July 10, 2023
(p)ppGpp and moonlighting RNases influence the first step of lipopolysaccharide biosynthesis in <i>Escherichia coli</i>Simon Brückner, Fabian Müller, Laura Schadowski, et al.
Advanced Drug Delivery Reviews|November 17, 2020
Clinically established biodegradable long acting injectables: An industry perspectiveChristian Isalomboto Nkanga, Andreas Fisch, Mazda Rad-Malekshahi, et al.
Clinical Rheumatology|March 10, 2025
Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohortAnnik Steimer, Andrea Götschi, Torsten Witte, et al.
RMD Open|June 23, 2026
Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management RegistryAnnik Steimer, Andrea Götschi, Jonas Brändli, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|December 16, 2011
Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination studySabine Adler, Anne Krivine, Janine Weix, et al.
The Journal of Allergy and Clinical Immunology|November 17, 2012
Induction of severe systemic lupus erythematosus by TNF blockade and response to anti-IL-6 strategySabine Adler, Mirjam Kolev, Pierre-Alain Varisco, et al.
Arthritis Research & Therapy|March 14, 2024
Concomitant Sjögren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohortLisa Christ, Seraphina Kissling, Axel Finckh, et al.
Rheumatology (Oxford, England)|March 13, 2018
Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritisStephan Reichenbach, Sabine Adler, Harald Bonel, et al.
Lancet (London, England)|March 9, 2016
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialPeter M Villiger, Sabine Adler, Stefan Kuchen, et al.
PLOS Digital Health|June 27, 2024
Explainable deep learning for disease activity prediction in chronic inflammatory joint diseasesCécile Trottet, Ahmed Allam, Aron N Horvath, et al.
Microlife|July 10, 2023
(p)ppGpp and moonlighting RNases influence the first step of lipopolysaccharide biosynthesis in <i>Escherichia coli</i>Simon Brückner, Fabian Müller, Laura Schadowski, et al.
Advanced Drug Delivery Reviews|November 17, 2020
Clinically established biodegradable long acting injectables: An industry perspectiveChristian Isalomboto Nkanga, Andreas Fisch, Mazda Rad-Malekshahi, et al.
Clinical Rheumatology|March 10, 2025
Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohortAnnik Steimer, Andrea Götschi, Torsten Witte, et al.
RMD Open|June 23, 2026
Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management RegistryAnnik Steimer, Andrea Götschi, Jonas Brändli, et al.
Pageof 5